Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
36.50
+1.67 (4.79%)
At close: Aug 13, 2025, 4:00 PM
36.90
+0.40 (1.10%)
After-hours: Aug 13, 2025, 7:00 PM EDT
Harrow Employees
Harrow had 382 employees as of December 31, 2024. The number of employees increased by 67 or 21.27% compared to the previous year.
Employees
382
Change (1Y)
67
Growth (1Y)
21.27%
Revenue / Employee
$595,971
Profits / Employee
-$26,775
Market Cap
1.35B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
HROW News
- 1 hour ago - Harrow: Exciting Times In Store - Seeking Alpha
- 1 day ago - Harrow, Inc. (HROW) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Harrow Announces Second-Quarter 2025 Financial Results - GlobeNewsWire
- 7 days ago - Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Conference - GlobeNewsWire
- 15 days ago - Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025 - GlobeNewsWire
- 27 days ago - Harrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United States - Business Wire
- 27 days ago - Samsung Bioepis Enters into a Partnership with Harrow for Commercialization of Ophthalmology Biosimilars Portfolio in the United States - Business Wire
- 4 weeks ago - HROW Investors Have Opportunity to Join Harrow, Inc. Fraud Investigation with the Schall Law Firm - PRNewsWire